Immunex Pharmaceuticals Private Limited

Immunex Pharmaceuticals Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U51392MH1994PTC078973 Incorporated 14 June 1994 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹12.77 Lakh
▼ 38% YoY
Net profit · FY 2025
₹3.38 Lakh
Net margin 26.5%
EBITDA · FY 2025
₹4.4 Lakh
EBITDA margin 34.4%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹93.78 Lakh
Issued & subscribed
Company age
32 yrs
Est. 1994
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered

About Immunex Pharmaceuticals Private Limited

Data last updated:

Immunex Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 14 June 1994 and has been in existence for over 32 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51392MH1994PTC078973. Its GSTIN is 27AAACI1095E1ZT (Maharashtra).

The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹93.78 Lakh. It is led by directors including Shivam Rajiv Bohra and Ashutosh Rajiv Bohra.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 74/80 Babu Genu Roadsouri Bldg 3rd Floor Kalbadevi Road, Mumbai, Maharashtra, India – 400002.

As per the financials filed for FY 2025, the company reported a revenue of ₹12.77 Lakh, a decline of 38% compared to the previous year. For the same year it recorded a net profit of ₹3.38 Lakh (net margin 26.5%) and EBITDA of ₹4.4 Lakh (EBITDA margin 34.4%). Revenue has declined at a compounded annual rate (CAGR) of 13% over three years and 2% over five years.

Court records list 6 cases involving the company, including 6 filed by the company; 1 case is pending.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U51392MH1994PTC078973
Registration Number 078973
Incorporation Date 14 June 1994
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Contact details

Immunex Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.

  • Email
  • Registered Address
    74/80 Babu Genu Roadsouri Bldg 3rd Floor Kalbadevi Road, Mumbai, Maharashtra, India – 400002
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Immunex Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Immunex Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Immunex Pharmaceuticals is support service to organizations. In detail, this covers other support services to organizations.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
NSupport service to OrganizationsN7Other support services to organizations

To see the full business activity and turnover split of Immunex Pharmaceuticals Private Limited, buy the company report.

Financials of Immunex Pharmaceuticals Private Limited

FY 2025 filings available

Immunex Pharmaceuticals Private Limited reported revenue of ₹12.77 Lakh (down 38% YoY) for FY 2025.

Revenue · FY 2025
₹12.77 Lakh ▼ 38%
Net profit · FY 2025
₹3.38 Lakh margin 26.5%
EBITDA · FY 2025
₹4.4 Lakh margin 34.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 38%
3 years · compounded
▼ 13%
5 years · compounded
▼ 2%
EBITDA CAGR growth
1 year
▼ 69%
3 years · compounded
▲ 28%
5 years · compounded
▲ 26%

Revenue has declined at a compounded annual rate (CAGR) of 2% over five years, including a 38% fall in the latest year. EBITDA fell 69% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹4.4 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹3.38 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin34.4%
Net Profit Margin26.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Immunex Pharmaceuticals Private Limited, buy the company report.

Board of directors of Immunex Pharmaceuticals Private Limited

Immunex Pharmaceuticals has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Shivam Rajiv BohraDirector14 Feb 20206 Years 8 MonthsCurrent
Ashutosh Rajiv BohraDirector10 Feb 20233 Years 8 MonthsCurrent
Rajiv Bijayshankar BohraDirector02 Sep 201313 Years 2 MonthsCurrent

Auditor

Immunex Pharmaceuticals Private Limited is audited by SHANKARLAL JAIN & ASSOCIATES LLP for the financial year 2018.

Auditor firmFinancial yearFirm registration number
SHANKARLAL JAIN & ASSOCIATES LLPFY 2018109901W

Shareholding

The shareholding of Immunex Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2018FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Immunex Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Immunex Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Immunex Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAACI1095E1ZTMaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Immunex Pharmaceuticals Private Limited, buy the company report.

Recent activity

Immunex Pharmaceuticals Private Limited has 9 board changes on record since 2013: 3 appointments and 6 cessations. The latest: Ashutosh Rajiv Bohra ceased to be Additional Director on 29 Sep 2023.

AGM
Immunex Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Immunex Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Ceased
Ashutosh Rajiv Bohra ceased to be Additional Director.
Appointed
Ashutosh Rajiv Bohra was appointed as Director.
Ceased
Chandrashekhar Bijayshankar Bohra ceased to be Director.
Ceased
Shivam Rajiv Bohra ceased to be Additional Director.
Appointed
Shivam Rajiv Bohra was appointed as Director.
Ceased
Pradip Kumar Dwivedi ceased to be Director.
Ceased
Rajiv Bijayshankar Bohra ceased to be Additional Director.
Appointed
Rajiv Bijayshankar Bohra was appointed as Director.
Ceased
Bijoyshankar Chiranjilal Bohra ceased to be Director.
Incorporation
14 Jun 1994
Immunex Pharmaceuticals Private Limited was registered on 14 Jun 1994 with Roc Mumbai I & aged 32 years 4 months as per MCA records.

Frequently asked questions

Immunex Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 14 June 1994 (32+ years old) and is registered under CIN U51392MH1994PTC078973.

Immunex Pharmaceuticals has 3 current directors:

The latest financial statements of Immunex Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Immunex Pharmaceuticals is 27AAACI1095E1ZT, registered in Maharashtra.

The CIN (Corporate Identification Number) of Immunex Pharmaceuticals is U51392MH1994PTC078973. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Immunex Pharmaceuticals has 6 court cases on record: 6 filed by the company. 1 is pending.

Immunex Pharmaceuticals was incorporated on 14 June 1994, making it 32+ years old. It is registered with the Registrar of Companies, Mumbai.

Ashutosh Rajiv Bohra ceased to be Additional Director on 29 Sep 2023. Ashutosh Rajiv Bohra was appointed as Director on 10 Feb 2023. Chandrashekhar Bijayshankar Bohra ceased to be Director on 10 Mar 2021. Immunex Pharmaceuticals has 9 board changes on record in total.

The registered office of Immunex Pharmaceuticals is at 7480 Babu Genu Roadsouri Bldg 3rd Floor Kalbadevi Road, Mumbai, Maharashtra, India – 400002.

Immunex Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.